WA
EW icon

Westfuller Advisors’s Edwards Lifesciences EW Stock Holding History

Westfuller Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$79.8K Buy
996
+58
+6% +$4.78K 0.03% 229
2025
Q4 		$80K Sell
938
-74
-7% -$6.07K 0.03% 250
2025
Q3 		$78.7K Buy
+1,012
New +$79.1K 0.04% 245

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Westfuller Advisors's EW Position: Q1 2026 in Review

Westfuller Advisors increased its Edwards Lifesciences (EW) stake by 6.2% in Q1 2026, buying an estimated $4.78K and bringing the position to 996 shares worth $79.8K. The position accounts for 0.03% of the portfolio, ranked #229.

Westfuller Advisors first reported a position in EW in Q3 2025 and has held it in 3 quarters since. The position peaked at $80K in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Westfuller Advisors held 996 shares of Edwards Lifesciences worth $79.8K as of Q1 2026.
  • Westfuller Advisors bought 58 Edwards Lifesciences shares in Q1 2026, an estimated $4.78K.
  • Edwards Lifesciences made up 0.03% of Westfuller Advisors's portfolio in Q1 2026, its #229 holding.
  • Westfuller Advisors first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 3 quarters since.
  • Westfuller Advisors's Edwards Lifesciences position peaked at $80K in Q4 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.